Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,799 | 16,613 | 8,441 | 11,463 | 15,507 |
| Receivables | 118 | 493 | 355 | 182 | 172 |
| Inventories | 221 | 227 | 254 | 269 | 258 |
| Other current assets | 39 | 46 | 45 | 42 | 48 |
| TOTAL | $15,850 | $19,436 | $10,992 | $14,121 | $18,021 |
| Non-Current Assets | |||||
| PPE Net | 59 | 60 | 64 | 68 | 50 |
| Other Non-Current Assets | 15 | 25 | 41 | 55 | 70 |
| TOTAL | $74 | $85 | $104 | $123 | $120 |
| Total Assets | $15,924 | $19,521 | $11,097 | $14,243 | $18,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,862 | 3,678 | 3,294 | 2,930 | 3,628 |
| TOTAL | $2,876 | $3,831 | $3,420 | $3,035 | $3,707 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 18 | 45 | 72 | 98 |
| Other Non-Current Liabilities | 0 | 0 | 5 | 10 | 15 |
| TOTAL | $N/A | $18 | $50 | $82 | $113 |
| Total Liabilities | $2,876 | $3,849 | $3,470 | $3,117 | $3,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,417 | 8,405 | 6,455 | 6,438 | 6,359 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -51,120 | -48,349 | -45,556 | -41,696 | -38,099 |
| TOTAL | $13,048 | $15,672 | $7,627 | $11,126 | $14,322 |
| Total Liabilities And Equity | $15,924 | $19,521 | $11,097 | $14,243 | $18,141 |